Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Judge approves Purdue Pharma bankruptcy plan

By Brian Buntz | September 2, 2021

Purdue PharmaPurdue Pharma may have reached a bankruptcy settlement in the U.S. Bankruptcy Court in White Plains, New York, but several states intend to press forward by appealing the decision of Judge Robert Drain. 

Judge Drain’s decision would direct $4.5 billion over a decade to support measures intended to fight the opioid crisis. “Substantially all of Purdue’s assets will be transferred to a new company with a public-minded mission,” read part of a statement on the Purdue Pharma website. 

Purdue Pharma had previously agreed in principle to a $3 billion bankruptcy agreement in September 2019.

The Sackler family that owned the company won immunity against further legal action in the Chapter 11 bankruptcy deal. The Sacklers furthermore will be barred from dealings with other pharmaceutical companies. 

Last week, Drain had surmised that the Sacklers faced a “substantial risk” of being “liable for huge amounts of money.”

The deal also forces the Sacklers to relinquish control over the firm. 

The firm will not disappear but will persist under the ownership of the National Opioid Abatement Trust (NOAT). Indian Tribes and Tribal Organization will hold a minority interest.

“We are disappointed with today’s ruling confirming the plan of reorganization for Purdue Pharma by the United States Bankruptcy Court for the Southern District of New York,” said Maryland Attorney General Brian E. Frosh in a statement. “This plan releases from liability members of the Sackler family and others who participated in or directed Purdue’s illegal acts that contributed to the opioid crisis.”

At least nine states have objected to the bankruptcy deal.  

Some 500,000 people have died in the wake of the opioid crisis. In 2019, HHS estimated that 10 million people had abused opioids.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE